Correlation Between VTC Telecommunicatio and Daklak Pharmaceutical

Can any of the company-specific risk be diversified away by investing in both VTC Telecommunicatio and Daklak Pharmaceutical at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining VTC Telecommunicatio and Daklak Pharmaceutical into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between VTC Telecommunications JSC and Daklak Pharmaceutical Medical, you can compare the effects of market volatilities on VTC Telecommunicatio and Daklak Pharmaceutical and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in VTC Telecommunicatio with a short position of Daklak Pharmaceutical. Check out your portfolio center. Please also check ongoing floating volatility patterns of VTC Telecommunicatio and Daklak Pharmaceutical.

Diversification Opportunities for VTC Telecommunicatio and Daklak Pharmaceutical

0.0

Correlation Coefficient

VTC Telecommunicatio  Daklak Pharmaceutical

Pay attention - limited upside

The 3 months correlation between VTC and Daklak is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding VTC Telecommunications JSC and Daklak Pharmaceutical Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Daklak Pharmaceutical and VTC Telecommunicatio is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on VTC Telecommunications JSC are associated (or correlated) with Daklak Pharmaceutical. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Daklak Pharmaceutical has no effect on the direction of VTC Telecommunicatio i.e., VTC Telecommunicatio and Daklak Pharmaceutical go up and down completely randomly.

Pair Corralation between VTC Telecommunicatio and Daklak Pharmaceutical

If you would invest  904,078  in VTC Telecommunications JSC on September 26, 2024 and sell it today you would lose (54,078) from holding VTC Telecommunications JSC or give up 5.98% of portfolio value over 90 days.

Time Period	3 Months [change]
Direction	Flat
Strength	Insignificant
Accuracy	0.0%
Values	Daily Returns

VTC Telecommunications JSC  vs.  Daklak Pharmaceutical Medical

VTC Telecommunications

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days VTC Telecommunications JSC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental indicators, VTC Telecommunicatio is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Daklak Pharmaceutical

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Daklak Pharmaceutical Medical has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of very healthy fundamental drivers, Daklak Pharmaceutical is not utilizing all of its potentials. The recent stock price disarray, may contribute to short-term losses for the investors.

Pair Trading with VTC Telecommunicatio and Daklak Pharmaceutical

The main advantage of trading using opposite VTC Telecommunicatio and Daklak Pharmaceutical positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if VTC Telecommunicatio position performs unexpectedly, Daklak Pharmaceutical can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Daklak Pharmaceutical will offset losses from the drop in Daklak Pharmaceutical's long position.

The idea behind VTC Telecommunications JSC and Daklak Pharmaceutical Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.